Reaction

Pancreatic Disorder reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 4,854 reports · 123 co-occurring drugs

As of the last recalculation, Pancreatic Disorder appears in 4,854 FAERS reports alongside 123 co-occurring drug terms. The strongest observed disproportionality signal is PANCRELIPASE (PRR 46.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Pancrelipase	384	46.2	46.7
Octreotide Acetate	95	13.5	13.6
Teduglutide	39	12.5	12.5
Lanreotide Acetate	18	9.9	9.9
Elexacaftor, Tezacaftor, And Ivacaftor	23	7.9	8.0
Insulin Human	60	6.5	6.5
Insulin Degludec	35	6.4	6.4
Insulin Lispro	200	6.4	6.4
Insulin Glulisine	15	6.3	6.4
Dicyclomine Hydrochloride	20	6.0	6.0
Dulaglutide	121	6.0	6.0
Insulin Glargine-Yfgn	30	5.9	5.9
Insulin Aspart	89	5.9	5.9
Cholestyramine	16	5.7	5.7
Psyllium Husk	13	5.7	5.7
Diclofenac Potassium, Film Coated	11	5.6	5.6
Diclofenac Potassium Tablets	11	5.6	5.6
Ivacaftor	10	5.4	5.4
Nilotinib	35	5.1	5.1
Amlodipine Besylate And Benazepril Hydrochloride	11	5.1	5.1
Insulin Glargine	279	5.1	5.1
Promethazine Hydrochloride	21	4.9	4.9
Liraglutide	55	4.8	4.8
Sitagliptin	79	4.8	4.8
Exenatide	57	4.7	4.7
Oral Semaglutide	79	4.7	4.7
Olanzapine Pamoate	44	4.6	4.6
Sucralfate	25	4.5	4.5
Abacavir Sulfate	10	4.4	4.4
Diclofenac Potassium	11	4.4	4.4
Cyclobenzaprine Hydrochloride	9	4.3	4.3
Tizanidine Hydrochloride	18	4.3	4.3
Doxepin	10	4.2	4.2
Hyoscyamine Sulfate	9	4.2	4.2
Glimepiride	38	4.2	4.2
Human Insulin	12	4.1	4.1
Gemfibrozil	14	4.0	4.0
Glyburide	22	3.9	3.9
Diphenhydramine Hcl	10	3.9	3.9
Sorafenib	18	3.7	3.7
Insulin	47	3.6	3.6
Sucralfate Oral	12	3.6	3.6
Sucralfate Oral Suspension	12	3.6	3.6
Epoprostenol	11	3.6	3.6
Sitagliptin And Metformin Hydrochloride	18	3.6	3.6
Linagliptin	15	3.5	3.5
Daspone	8	3.5	3.5
Dapsone Gel, 5%	8	3.5	3.5
Fenofibrate	29	3.5	3.5
Meclizine Hcl 12.5Mg	11	3.5	3.5
Meclizine Hcl 25Mg	11	3.5	3.5
Meclizine Hcl 12.5 Mg	11	3.5	3.5
Meclizine Hcl 25 Mg	11	3.5	3.5
Liothyronine Sodium	7	3.5	3.5
Pioglitazone	34	3.4	3.4
Nintedanib	24	3.3	3.3
Prochlorperazine Maleate	7	3.3	3.3
Diclofenac Sodium 1%	27	3.3	3.3
Diclofenac Sodium Topical	27	3.3	3.3
Diclofenac Sodium Topical Gel, 1%	27	3.2	3.2
Loperamide Hydrochloride And Dimethicone	24	3.2	3.2
Dapsone	8	3.2	3.2
Goserelin	10	3.2	3.2
Glipizide	45	3.2	3.2
Loperamide Hydrochloride	32	3.1	3.1
Meclizine Hydrochloride	14	3.1	3.1
Rifaximin	14	2.9	2.9
Bosutinib	6	2.9	2.9
Dabrafenib	14	2.9	2.9
Darunavir	10	2.8	2.8
Iron Sucrose	6	2.7	2.7
Metformin Er 500 Mg	178	2.6	2.6
Metformin Er 750 Mg	178	2.6	2.6
Pazopanib Hydrochloride	16	2.5	2.5
Risankizumab-Rzaa	48	2.5	2.5
Tirzepatide	89	2.4	2.4
Nevirapine	5	2.4	2.4
Everolimus	28	2.4	2.4
Pembrolizumab	57	2.3	2.3
Metformin Hcl	29	2.3	2.3
Regorafenib	6	2.2	2.2
Pemetrexed	11	2.2	2.2
Tobramycin	12	2.1	2.1
Asfotase Alfa	5	2.1	2.1
Drospirenone And Ethinyl Estradiol	22	2.1	2.1
Deferasirox	13	2.1	2.1
Linaclotide	13	2.1	2.1
Orlistat	12	2.0	2.0
Tenofovir Disoproxil Fumarate Tablets	4	2.0	2.0
Trametinib	11	2.0	2.0
Durvalumab	9	1.9	1.9
Eculizumab	24	1.9	1.9
Patiromer	6	1.9	1.9
Imatinib Mesylate	12	1.8	1.8
Cariprazine	4	1.8	1.8
Nivolumab	41	1.8	1.8
Vedolizumab	36	1.8	1.8
Atezolizumab	16	1.8	1.8
Sunitinib Malate	16	1.7	1.7
Canagliflozin	12	1.7	1.7
Tenofovir Disoproxil Fumarate	13	1.7	1.7
Olaparib	8	1.6	1.6
Gemcitabine	15	1.6	1.6
Gemcitabine Hydrochloride	20	1.6	1.6
Loratadine And Pseudoephedrine Sulfate	3	1.6	1.6
Pemetrexed Disodium	14	1.6	1.6
Lenvatinib	12	1.6	1.6
Glecaprevir And Pibrentasvir	4	1.6	1.6
Hydrocodone Bitartrate And Acetaminophen	20	1.5	1.5
Cabozantinib	17	1.5	1.5
Ruxolitinib	25	1.5	1.5
Oxymorphone Hydrochloride	4	1.5	1.5
Ribavirin	22	1.5	1.5
Teriparatide	37	1.4	1.4
Belimumab	10	1.4	1.4
Axitinib	6	1.3	1.3
Dornase Alfa	6	1.3	1.3
Ipilimumab	13	1.3	1.3
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	9	1.2	1.2
Emtricitabine And Tenofovir Alafenamide	3	1.1	1.1
Cenegermin-Bkbj	3	1.1	1.1
Velpatasvir And Sofosbuvir	3	1.0	1.0
Evolocumab	35	0.9	0.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.